446 results on '"Kouanfack, Charles"'
Search Results
2. Feasibility, safety, efficacy and potential scaling-up of sofosbuvir-based HCV treatment in Central and West Africa: (TAC ANRS 12311 trial)
3. Genomic surveillance of SARS-CoV-2 reveals highest severity and mortality of delta over other variants: evidence from Cameroon
4. Relation between interleukin-6 concentrations and oxidative status of HIV infected patients with /or at risk of Kaposi disease in Yaounde
5. Faecal carriage of multidrug-resistant and extended-spectrum β-lactamase-producing Enterobacterales in people living with HIV in Yaoundé, Cameroon
6. Reduction in mortality from HIV-related CNS infections in routine care in Africa (DREAMM): a before-and-after, implementation study
7. Patient-reported outcomes with direct-acting antiviral treatment for hepatitis C in West and Central Africa (TAC ANRS 12311 trial)
8. Non-inferiority test for a continuous variable with a flexible margin in an active controlled trial: an application to the “Stratall ANRS 12110 / ESTHER” trial
9. Cost-utility analysis of four WHO-recommended sofosbuvir-based regimens for the treatment of chronic hepatitis C in sub-Saharan Africa
10. APOL1 Renal Risk Variants and Kidney Function in HIV-1–Infected People From Sub-Saharan Africa
11. Low CD4 counts predict excessive weight gains during first-line treatment for HIV.
12. Prevalence, Epidemiological, and Clinical Profile of Patients Coinfected with Human Immunodeficiency Virus and Tuberculosis in the Coronavirus Disease 2019 Context in Health Facilities in the East Region, Cameroon
13. Distribution and Antifungal Resistance Profile of <i>Candida</i> spp. Isolated from Patients Living with HIV at the Yaoundé Central Hospital
14. The Feasibility and Acceptability of Using Mobile Applications for HIV Testing, Prevention, and Treatment Among Adolescent Girls and Young Women in Cameroon: A Cross-Sectional Study
15. Demographic, Behavioural and Clinical Characteristics of HIV-infected Adults Initiating Antiretroviral Therapy in Rural ART Clinics in the Centre Region of Cameroon
16. Viral Load Suppression Among HIV Infected Adults On Antiretroviral Treatment In Rural Settings Of The Centre Region Of Cameroon: A Retrospective Cohort Study
17. A Bayesian analysis of birth pulse effects on the probability of detecting Ebola virus in fruit bats
18. A Bayesian analysis of birth pulse effects on the probability of detecting Ebola virus in fruit bats
19. Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open label, phase 3 non-inferiority trial in Cameroon
20. A detailed characterization of drug resistance during darunavir/ritonavir monotherapy highlights a high barrier to the emergence of resistance mutations in protease but identifies alternative pathways of resistance
21. PA-595 Hepatotoxicity associated to N-Acetyltransferase type 2 polymorphisms in TB patients with malaria at Jamot Hospital, Yaoundé, Cameroon
22. Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries
23. Feasability and effectiveness of scaling up hepatitis-C treatment in West and Central Africa: the TAC ANRS 12311 clinical trial
24. Genetic diversity and microevolution in clinical Cryptococcus isolates from Cameroon
25. Doxycycline vs Hydroxychloroquine + Azithromycin in the Management of COVID-19 Patients: An Open-Label Randomized Clinical Trial in Sub-Saharan Africa (DOXYCOV)
26. Risks of metabolic syndrome in the ADVANCE and NAMSAL trials
27. Extensive Survey and Analysis of Factors Associated with Presence of Antibodies to Orthoebolaviruses in Bats from West and Central Africa
28. Information and communication are key for hepatitis B elimination in Francophone Africa: Insights from a survey among healthcare providers
29. A Bayesian analysis of birth pulse effects on the probability of detecting Ebola virus in fruit bats
30. Performance evaluation of the novel portable PIMA point-of-care CD4 analyzer in comparison with conventional flow cytometer instruments in Cameroon
31. A detailed characterization of drug resistance during darunavir/ritonavir monotherapy highlights a high barrier to the emergence of resistance mutations in protease but identifies alternative pathways of resistance.
32. Durability of the Efficacy and Safety of Dolutegravir-Based and Low-Dose Efavirenz–Based Regimens for the Initial Treatment of Human Immunodeficiency Virus Type 1 Infection in Cameroon: Week 192 Data of the NAMSAL-ANRS-12313 Study.
33. The benefits of traditional birth attendants on maternal and fetal outcomes in sub-Saharan Africa: A systematic review and meta-analysis
34. Large diffusion of SARS-CoV-2 after the successive epidemiological waves, including Omicron, in Guinea and Cameroon: implications for vaccine strategies
35. Extensive survey and analysis of factors associated with presence of antibodies to orthoebolaviruses in bats from West and Central Africa
36. Risks of metabolic syndrome in the ADVANCE and NAMSAL trials.
37. Coronaviruses Are Abundant and Genetically Diverse in West and Central African Bats, including Viruses Closely Related to Human Coronaviruses
38. Universal test and treat in Cameroon: a comparative retrospective analysis of mortality and loss to follow-up before and after a strategic change in approach to HIV care
39. Contribution of community-based organizations in the improvement of Joint United Nations Program on HIV and AIDS 90-90-90: case of the Yaoundé Central Hospital
40. Evaluation of Circulating and Archived HIV-1 Integrase Drug-Resistance Variants among Patients on Third-Line ART in Cameroon: Implications for Dolutegravir-Containing Regimens in Resource-Limited Settings
41. Dolutegravir-Based Regimen Ensures High Virological Success despite Prior Exposure to Efavirenz-Based First-LINE ART in Cameroon: An Evidence of a Successful Transition Model
42. Effect of Covid-19 Pandemic on the Management of Medical Emergencies at the Yaounde Emergency Centre
43. Effect of the COVID-19 pandemic on the financial revenues of public hospitals with a care centre: case of the Yaoundé Central Hospital
44. S7.1d Reliability of bedside point-of-care tests for Candida neoformans , M. tuberculosis and S. pneumoniae in adults living with HIV presenting with suspected central nervous system infection (CNS) in low- and middle-income settings: Preliminary results from the DREAMM study
45. P449 Semi-quantitative cryptococcal antigen rapid test (CryptoPS, Biosynex®) for cryptococcal meningitis in patients living with HIV in Sub-Saharan Africa: prospective multicenter diagnostic accuracy study (DREAMM)
46. Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa
47. Bio-monitoring of mycotoxin exposure in Cameroon using a urinary multi-biomarker approach
48. Monitoring of HIV viral load, CD4 cell count, and clinical assessment versus clinical monitoring alone for antiretroviral therapy in low-resource settings (Stratall ANRS 12110/ESTHER): a cost-effectiveness analysis
49. Prediction of HIV Drug Resistance Based on Virologic, Immunologic, Clinical, and/or Adherence Criteria in the Stratall ANRS 12110/ESTHER Trial in Cameroon
50. Large Diffusion of Severe Acute Respiratory Syndrome Coronavirus 2 After the Successive Epidemiological Waves, Including Omicron, in Guinea and Cameroon: Implications for Vaccine Strategies.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.